Cerebrospinal fluid evidence of increased extra-mitochondrial glucose metabolism implicates mitochondrial dysfunction in multiple sclerosis disease progression.
In contrast to relapse, the mechanisms of multiple sclerosis (MS) disease progression are less understood and appear not to be exclusively inflammatory in nature. In this pilot study we investigated the relationship between disturbed CNS energy metabolism and MS disease progression. We tested the hypothesis that cerebrospinal fluid (CSF) concentrations of sorbitol, fructose, and lactate, all metabolites of extra-mitochondrial glucose metabolism, would be elevated in secondary progressive (SP) MS patients and would be associated with worsening neurologic disability. We measured metabolite concentrations by gas chromatographic/mass spectrometric and enzymatic methods in archived CSF samples from 85 MS patients [31 relapsing-remitting (RR) and 54 SP patients] and 18 healthy controls. We found that concentrations of all three metabolites, but not concentrations of glucose or myoinositol, were significantly increased in CSF from SP and, to a lesser degree, RR patients, compared to controls. Furthermore, CSF concentrations of sorbitol and fructose (polyol pathway metabolites), but not lactate (anaerobic glycolysis metabolite), correlated positively and significantly with Expanded Disability Status Scale (EDSS) score, an index of neurologic disability in MS patients. We conclude that extra-mitochondrial glucose metabolism is increased in MS patients and is associated with disease progression evidenced by increasing EDSS score. As extra-mitochondrial glucose metabolism increases with impaired mitochondrial metabolism of glucose, these findings implicate mitochondrial dysfunction in the pathogenesis of MS disease progression. CSF metabolic profiling may be useful in clarifying the role of mitochondrial pathology in progression and in targeting and monitoring therapies for disease progression that aim to preserve or boost mitochondrial glucose metabolism.
Regenold
William T
WT
University of Maryland School of Medicine, Department of Psychiatry, Division of Geriatric Psychiatry, Baltimore, MD 21201, USA. wregenol@psych.umaryland.edu
Phatak
Pornima
P
Makley
Michael J
MJ
Stone
Roger D
RD
Kling
Mitchel A
MA
D000328:Adult; D000704:Analysis of Variance; D018450:Disease Progression; D005260:Female; D005632:Fructose / Q000134:cerebrospinal fluid; D005947:Glucose / Q000378:metabolism*; D006801:Humans; D019344:Lactic Acid / Q000134:cerebrospinal fluid; D008297:Male; D008875:Middle Aged; D008928:Mitochondria / Q000378:metabolism*; D028361:Mitochondrial Diseases / Q000209:etiology* / Q000473:pathology; D009103:Multiple Sclerosis / Q000134:cerebrospinal fluid* / Q000145:classification / Q000150:complications*; D010865:Pilot Projects; D013012:Sorbitol / Q000134:cerebrospinal fluid; D055815:Young Adult
D005632:Fructose; D019344:Lactic Acid; D013012:Sorbitol; D005947:Glucose
Neuromolecular Med. 2003;3(3):147-58
12835510
J Neurol Neurosurg Psychiatry. 1964 Oct;27:415-21
14213470
Diabetologia. 1966 Sep;2(2):82-5
6005214
J Chromatogr. 1984 Dec 12;336(2):351-5
6530467
Brain. 1988 Oct;111 ( Pt 5):1009-24
3263167
Eur J Pediatr. 1995;154(7 Suppl 2):S53-64
7671966
Eur J Neurol. 2007 Jan;14(1):44-7
17222112
Philos Trans R Soc Lond B Biol Sci. 1999 Jul 29;354(1387):1155-63
10466143
J Neurosurg. 1989 Feb;70(2):183-9
2913216
Clin Chem. 1996 Feb;42(2):298-302
8595727
Can J Neurol Sci. 1993 Aug;20(3):194-8
8221382
J Biol Chem. 2006 Oct 20;281(42):31950-62
16920708
N Engl J Med. 2000 Nov 16;343(20):1486-7
11078776
Acta Endocrinol Suppl (Copenh). 1980;238:133-7
6933810
Acta Neurol Scand. 1997 Jan;95(1):9-12
9048978
Acta Neurol Scand. 1977 Aug;56(2):104-10
899714
J Affect Disord. 2005 Apr;85(3):341-50
15780705
J Neurol Sci. 1996 Dec;144(1-2):182-90
8994122
J Clin Invest. 1995 Feb;95(2):542-6
7860736
Psychoneuroendocrinology. 2000 Aug;25(6):593-606
10840171
N Engl J Med. 2000 Nov 16;343(20):1430-8
11078767
Nat Med. 2007 Dec;13(12):1483-9
17994101
Acta Neurol Scand. 1998 Oct;98(4):232-7
9808271
Neurology. 2004 Apr 27;62(8):1297-302
15111665
Annu Rev Med. 1975;26:521-36
238458
J Neuroimmunol. 2007 Aug;188(1-2):1-12
17493689
Acta Med Austriaca. 2001;28(5):152-5
11774778
PLoS One. 2007 Jul 04;2(7):e595
17611627
Acta Neurol Scand. 1989 Dec;80(6):561-8
2515713
J Neurol Neurosurg Psychiatry. 1997 Mar;62(3):290
9069491
J Pediatr. 2001 Feb;138(2):260-2
11174626
J Cereb Blood Flow Metab. 2001 Jan;21(1):85-91
11149672
C R Acad Sci III. 1996 Jul;319(7):623-31
9011324
J Neurol Sci. 2000 Aug 15;177(2):95-103
10980305
Diabet Med. 1995 Jul;12(7):566-79
7554777
Anal Biochem. 1995 Jan 1;224(1):279-85
7710082
Clin Chem. 1995 Mar;41(3):343-60
7882508
Brain. 2005 May;128(Pt 5):1026-37
15728653
Neurology. 1970 May;20(5):1-59
4314823
J Neurol Neurosurg Psychiatry. 1997 Oct;63(4):446-51
9343121
Acta Neurol Scand. 1995 May;91(5):326-9
7639060
Ann Neurol. 1999 Dec;46(6):925-8
10589548
Ann Neurol. 2006 Mar;59(3):478-89
16392116
Mult Scler. 1995 Apr;1(1):32-6
9345467
Trends Mol Med. 2006 May;12(5):192-5
16574486